# Efficiency and Biocompatibility in Hemodiafiltration Procedure

> **NCT06807905** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 20 (actual)

## Conditions studied

- End Stage Renal Disease on Dialysis
- Biocompatibility
- Anticoagulation
- Hemodiafiltration

## Interventions

- **DRUG:** Heparin anticoagulation
- **DRUG:** Citrate anticoagulation

## Key facts

- **NCT ID:** NCT06807905
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2020-09-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807905, "Efficiency and Biocompatibility in Hemodiafiltration Procedure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06807905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*